Lasorella Anna, Stegmüller Judith, Guardavaccaro Daniele, Liu Guangchao, Carro Maria S, Rothschild Gerson, de la Torre-Ubieta Luis, Pagano Michele, Bonni Azad, Iavarone Antonio
Institute for Cancer Genetics, College of Physicians and Surgeons of Columbia University, New York, New York 10032, USA.
Nature. 2006 Jul 27;442(7101):471-4. doi: 10.1038/nature04895. Epub 2006 Jun 28.
In the developing nervous system, Id2 (inhibitor of DNA binding 2, also known as inhibitor of differentiation 2) enhances cell proliferation, promotes tumour progression and inhibits the activity of neurogenic basic helix-loop-helix (bHLH) transcription factors. The anaphase promoting complex/cyclosome and its activator Cdh1 (APC/C(Cdh1)) restrains axonal growth but the targets of APC/C(Cdh1) in neurons are unknown. Id2 and other members of the Id family are very unstable proteins that are eliminated as cells enter the quiescent state, but how they are targeted for degradation has remained elusive. Here we show that Id2 interacts with the core subunits of APC/C and Cdh1 in primary neurons. APC/C(Cdh1) targets Id2 for degradation through a destruction box motif (D box) that is conserved in Id1 and Id4. Depletion of Cdh1 stabilizes Id proteins in neurons, whereas Id2 D-box mutants are impaired for Cdh1 binding and remain stable in cells that exit from the cell cycle and contain active APC/C(Cdh1). Mutants of the Id2 D box enhance axonal growth in cerebellar granule neurons in vitro and in the context of the cerebellar cortex, and overcome the myelin inhibitory signals for growth. Conversely, activation of bHLH transcription factors induces a cluster of genes with potent axonal inhibitory functions including the gene coding for the Nogo receptor, a key transducer of myelin inhibition. Degradation of Id2 in neurons permits the accumulation of the Nogo receptor, thereby linking APC/C(Cdh1) activity with bHLH target genes for the inhibition of axonal growth. These findings indicate that deregulated Id activity might be useful to reprogramme quiescent neurons into the axonal growth mode.
在发育中的神经系统中,Id2(DNA结合抑制因子2,也称为分化抑制因子2)可增强细胞增殖、促进肿瘤进展并抑制神经源性碱性螺旋-环-螺旋(bHLH)转录因子的活性。后期促进复合物/细胞周期体及其激活因子Cdh1(APC/C(Cdh1))会抑制轴突生长,但APC/C(Cdh1)在神经元中的作用靶点尚不清楚。Id2和Id家族的其他成员是非常不稳定的蛋白质,在细胞进入静止状态时会被清除,但它们如何被靶向降解一直难以捉摸。在这里,我们表明Id2在原代神经元中与APC/C和Cdh1的核心亚基相互作用。APC/C(Cdh1)通过在Id1和Id4中保守的破坏框基序(D框)将Id2靶向降解。Cdh1的缺失会使神经元中的Id蛋白稳定,而Id2 D框突变体与Cdh1的结合受损,并在退出细胞周期并含有活性APC/C(Cdh1)的细胞中保持稳定。Id2 D框的突变体在体外和小脑皮质的环境中增强了小脑颗粒神经元的轴突生长,并克服了髓磷脂对生长的抑制信号。相反,bHLH转录因子的激活会诱导一组具有强大轴突抑制功能的基因,包括编码Nogo受体的基因,Nogo受体是髓磷脂抑制的关键转导因子。神经元中Id2的降解允许Nogo受体的积累,从而将APC/C(Cdh1)的活性与bHLH靶基因联系起来以抑制轴突生长。这些发现表明,失调的Id活性可能有助于将静止神经元重编程为轴突生长模式。